Articles tagged with Biomarkers
The study found that nicotinamide riboside (NR) increases NAD+ levels in the blood, which is associated with lower biomarkers of neurodegenerative disease. Researchers measured NAD+ directly in extracellular vesicles and found a correlation between increased NAD+ and changes in disease biomarkers.
Researchers found altered proteins in women's blood during the third trimester, correlating with brain signaling activity and pro-inflammatory pathways. The study aims to develop early diagnosis and treatment protocols for perinatal mood disorders.
The American Gastroenterological Association recommends integrating non-invasive biomarkers for patients with ulcerative colitis in remission or with current symptoms. Biomarkers provide accurate insights into disease activity, offering a cheaper and more convenient option for monitoring.
A recent study suggests that routine evaluation of HER2 expression in ductal carcinoma in situ (DCIS) is crucial to avoid under or overtreatment. The research found a significant association between HER2 overexpression and a higher risk of recurrence, as well as improved radiotherapy outcomes.
Researchers examined three epigenetic age acceleration measurements and found inverse associations with lung cancer risk in men and younger participants. However, these findings did not support a positive association between epigenetic age measures and lung cancer risk in the study.
Researchers at Duke-NUS Medical School have devised a way to rapidly and precisely measure the length of a single telomere, opening doors to developing lifestyle interventions that slow ageing and prevent disease. The novel approach uses DNA sequences called 'telobaits' to latch onto the ends of telomeres in large pools of DNA fragments.
A study found that cystatin C-based eGFR was strongly correlated with creatinine-based eGFR and that 27% of patients would be classified as having a more severe chronic kidney stage based on cystatin C test results. The use of cystatin C can lead to changes in CKD staging, which can impact clinical management.
Researchers have developed a novel prognostic index to predict survival outcomes in gastric cancer patients. The inflammation-combined prognostic index (ICPI) combines three biomarkers - lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio - to provide a personalized prognosis for each patient.
A University of Massachusetts Amherst epidemiologist is leading a team to better understand the effects of chronic stress on future health risks. They will examine metabolites in blood samples from a large, racially diverse population to identify potential biomarkers for heart disease, diabetes and cognitive decline.
Researchers studied brain activity in rats as they learned a fine motor task, discovering synchronous low-frequency oscillatory activity that coordinated neural spiking in the motor cortex and cerebellum. This activity may serve as a biomarker for skill learning and a target for electric stimulation to promote motor recovery after stroke.
The ESMO Gynaecological Cancers Congress 2023 will present the latest treatments and insights for ovarian, uterine, cervical, and rare gynaecological cancers. Around 80 studies will be presented on strategies to overcome PARP inhibitors mechanisms of resistance in ovarian cancer.
Researchers explore CEACAM1, CEACAM5, and CEACAM6's pathological significance in cancer biology and immunology. The review highlights their interactions with pathogens and potential avenues for cancer therapy.
Researchers have identified a new protein in the cerebrospinal fluid that can reliably detect endothelial injury, a key contributor to cognitive impairment in pre-symptomatic stages of Alzheimer's. The discovery offers hope for improving diagnostic tests and potentially preventing damage to the brain endothelium.
Researchers found differences in gut microbiomes of people with ME/CFS compared to healthy controls, indicating a potential role for the microbiome in the disease. Abnormal levels of specific bacteria and metabolites were associated with reduced butyrate production, which is essential for gut health.
A new biomarker, GFAP, has been identified that can predict both current and future progression of multiple sclerosis. Elevated blood levels of GFAP indicate chronic disease processes involving astrocytes, which contribute to gradual progressive disability.
The study validated the clinical utility of Strata Oncology's proprietary pan-solid tumor predictive biomarker, Immunotherapy Response Score (IRS), which predicts response to checkpoint inhibitor therapy. IRS captures tumor biology and microenvironment by combining tumor mutation burden with quantitative expression of PD-L1, PD-1, ADAM...
A study published in BMJ Open Diabetes Research & Care found that married individuals tend to have lower average glycemic levels compared to those without a partner. The researchers also discovered that marital transitions, such as divorce, can significantly impact blood glucose levels and the risk of pre-diabetes.
A new lifestyle-related biomarker, gluconic acid, is associated with high blood pressure and ischemic stroke in Black adults. The study suggests that a blood test measuring metabolites may help determine if diet and exercise are effective in lowering stroke risk.
Researchers at the University of South Australia are developing new biomarkers to improve melanoma detection and avoid delayed treatment. The current markers used in clinical practice are not always sensitive or specific, leading to fatal consequences if cancerous cells are missed.
The SWOG S1416 clinical trial demonstrated the efficacy of PARP inhibitor veliparib in patients with triple-negative breast cancer and a 'BRCA-like' phenotype. Patients treated with veliparib experienced longer progression-free survival times compared to those receiving chemotherapy alone, with median PFS of 5.9 months versus 4.2 months.
Researchers from TIBI have developed an advanced electronic skin patch that provides simultaneous, continuous monitoring of multiple bodily parameters. The new E-skin patch offers enhanced flexibility, thermal cooling abilities, and fluid absorption over conventional substrates while demonstrating excellent biocompatibility and biodegr...
Researchers from the University of Tsukuba have found distinct changes in brain activity patterns that can differentiate between Alzheimer's disease and Lewy body dementia. These changes were present before symptoms emerged and could be detected using conventional MRI.
Researchers identified a panel of novel blood biomarkers associated with sudden cardiac arrest, which have the potential to enhance clinical prediction. Additionally, an AI-powered ultrasound technology can accurately identify coronary artery calcium buildup, potentially replacing CT scans as a diagnostic tool.
A new DNA biosensor developed by NIST, Brown University, and the French government-funded research institute CEA-Leti boasts accurate and inexpensive design. The modular device can measure biomarkers in a scalable and high-sensitivity manner.
Biomarkers of bone turnover are essential for diagnosing and treating metabolic musculoskeletal diseases. The International Osteoporosis Foundation, IFCC, and ESCEO have collaborated to publish authoritative reviews on the use and interpretation of these biomarkers.
The team's sensor detects Tumour Necrosis Factor alpha (TNF alpha), a biomarker involved in inflammation, which is linked to various diseases including Alzheimer's. The biosensor is sensitive and can detect low concentrations of TNF alpha, making it a promising tool for early disease detection.
Researchers are launching a clinical trial testing azeliragon, a RAGE inhibitor, with chemoradiotherapy to re-sensitize brain tumours that resist radiotherapy. The trial aims to predict radioresistance in brain metastasis using liquid biopsy.
A Rutgers study found that pregnant people with HIV have higher levels of chronic systemic inflammation and immune activation, leading to poor growth in children. The study aimed to investigate the impact on babies exposed to HIV but not infected.
Swansea University scientists developed a smart patch that can detect proinflammatory biomarkers of neurodegenerative diseases, including Alzheimer's, using microneedle technology. The patches can be self-administered for point-of-care diagnosis and have the potential to change the landscape of early disease detection.
Researchers identified 17 clusters of single cells in peripheral blood, showing upregulation of antigen processing and presentation pathways and downregulation of genes involved in ribosome pathways with age. The study also found senescent T cells resistant to apoptosis, potentially targeted for treatment.
A new study by researchers at Florida Atlantic University explored the effects of resistance training on older adults' cellular level. The study found that resistance training did not significantly affect inflammatory proteins or redox balance markers, but showed a significant reduction in a specific protein ratio. This may support the...
Researchers analyzed data from the VITAL trial and found that vitamin D supplementation increased biomarkers associated with vitamin D metabolism in people, regardless of their weight. However, these increases were significantly smaller in people with elevated BMIs, suggesting a blunted response to supplementation.
Researchers have developed a novel blood-based biomarker, brain-derived tau (BD-tau), that specifically measures non-phosphorylated tau originating from the brain. This breakthrough addresses an unmet need for a blood test that tracks neurodegenerative changes in Alzheimer's disease but not in other dementias.
A new study has identified distinct patterns of circular RNA expression in human ALS muscle tissue, which display disease-specific gradients and could inform about neuromuscular molecular programs in ALS. The research reveals that specific circRNAs are elevated in ALS muscle biopsies but reduced in spinal cord samples from ALS patients.
Researchers at Ningbo University identified biomarkers in short-chain fatty acids that may indicate three common pregnancy complications: pre-eclampsia, gestational diabetes, and intrahepatic cholestasis. The study found elevated levels of isobutyric acid and other short-chain fatty acids in women with these conditions.
A new study identifies a protein called GFAP as a possible biomarker for very early stages of Alzheimer's disease, which can be detected ten years before symptoms arise. This breakthrough discovery could lead to earlier diagnosis and treatment of the disease.
Researchers have created a humanized mouse model that can predict the best match for a living organ donor and detect early signs of transplant rejection. The model uses a combination of HLA-G and B regulatory cells to identify patients who may need less immunosuppressive therapy.
Researchers found that impaired olfactory identification and sensitivity functions are associated with frailty, suggesting a potential biomarker for predicting frailty and unhealthy aging. The study's findings suggest screening older adults' ability to smell various scents could be as important as testing hearing and vision.
Researchers have discovered a new biomarker that predicts the response to CAR-T cell therapy in patients with diffuse large B cell lymphoma. The biomarker identifies differentiated T cells, which can be removed from leukemia products to improve therapy success rates.
Researchers from prominent institutions discuss hepatocellular carcinoma's pathogenesis, genomic heterogeneity, and targeted therapy options. The review aims to characterize HCC's complexities and develop clinically relevant biomarkers for better management.
African patients with chronic hepatitis B face limited access to treatment due to inadequate guidelines. Researchers propose lower treatment thresholds and better adapted guidelines for the African population.
Researchers developed a blood test using circulating microparticle proteins to predict placenta accreta spectrum (PAS) cases as early as the second trimester. The study found five unique proteins that can distinguish PAS patients from control patients, enabling safe predication before delivery.
A new study found that measuring activation of immune-system B cells may be better than measuring either T-cell activation or total number of immune cells in and around a tumor. The findings suggest that six signatures of immune cell gene activation from B cells were associated with higher elimination rates and better survival outcomes.
A team from Brigham and Women's Hospital developed FIND-seq, a method that isolates and analyzes rare astrocytes driving MS inflammation and neurodegeneration. This approach identified signaling pathways controlling the development of pathogenic astrocytes in mice and humans.
Researchers examined associations between APOE ε2 and ε4 alleles, polygenic profiles, and Alzheimer's disease biomarkers. They found links between ε4 alleles with plasma and CSF Aβ42 and CSF tau, as well as differences in associations with tau and Aβ42.
The American Psychiatric Association's January journal issues focus on childhood- and neurodevelopment-related psychiatric disorders. A study published in The American Journal of Psychiatry explores how brain scans predict treatment response to psychotherapy for OCD.
A 16-year longitudinal study found associations between DNA methylation-based measures and neuropsychologically-validated cognitive decline in midlife. The results suggest that these measures may serve as biomarkers for a molecular aging mechanism, potentially identifying individuals at risk of cognitive impairment and dementia.
A new biomarker test, called BD-tau, can detect Alzheimer's disease neurodegeneration in blood samples with high accuracy. The test outperforms current methods and correlates well with CSF biomarkers, providing a valuable tool for improved diagnosis and clinical trial design.
Researchers found that plasma GH levels are a potential biomarker for predicting treatment outcomes in patients with advanced HCC treated with Atezo/Bev. The study showed significantly superior overall survival and non-significant trend in favor of GH-low patients compared to GH-high patients.
Researchers developed a new epigenetic biomarker, GrimAge version 2, which leverages two DNAm-based estimators of plasma proteins to predict mortality risk. The study found that GrimAge 2 outperforms existing clinical biomarkers in predicting mortality across multiple racial/ethnic groups and associations with age-related conditions.
A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...
Researchers at Michigan Medicine have developed a new biomarker-based strategy to screen for immune checkpoint inhibitor-induced myocarditis, which can cause muscle damage and liver injury. Early detection of these biomarkers can lead to earlier treatment and improved survival rates.
A recent clinical trial found that walnut consumption reduced stress and depression levels in university students. The study also showed improved metabolic biomarkers and overall sleep quality in the longer term. Walnuts contain nutrients like omega-3 fatty acids, antioxidants, and melatonin, which promote healthy brain and gut function.
The study reveals that SETD1A overexpression is associated with poorer disease-free survival in pancreatic cancer patients. Artificially cultured cells showed increased cell growth and migration when SETD1A levels were overexpressed, while knocking down SETD1A expression led to decreased RUVBL1 gene expression.
Researchers investigate how lung cancers evade the immune system to develop more effective immunotherapy treatments. The study aims to uncover a new way lung cancers disguise themselves from the immune system, potentially leading to improved treatment outcomes.
A new study identifies anti-Müllerian hormone (AMH) as a key factor in regulating cholesterol levels during the menopause transition. High AMH levels are associated with lower HDL-C, or good cholesterol, which may indicate cardiovascular risk despite its traditionally protective effects.
Researchers found that lncRNA MVIH is overexpressed in cervical cancer tumors and associated with younger age, lymph node metastasis, tumor invasion depth, and squamous cell type. This suggests its potential as a diagnostic biomarker for cervical cancer.
A study found that antibodies to common antibiotic gentamicin are associated with an increased risk of progression to type 1 diabetes in children already genetically at risk. The researchers also identified an association between the FUT2 gene and the production of these antibodies, which may be compounding risks for type 1 diabetes.
A new analytical method has been developed to map climatic and environmental processes at high temporal resolution, revealing an abrupt intensification of seasonality in the tropical ocean during the last period of global climate change. This provides evidence of how global climate changes affect local, seasonal temperature variations.
Researchers from the Leibniz Institute for Food Systems Biology have identified three metabolites as potential biomarkers for individual coffee consumption. These biomarkers could help determine the health value of coffee by objectively verifying coffee consumption levels.